Why Cisco Systems, Inc. (CSCO) Is Poised to Outperform

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool’s free investing community, networking giant Cisco Systems, Inc. (NASDAQ:CSCO) has earned a coveted four-star ranking.

With that in mind, let’s take a closer look at Cisco and see what CAPS investors are saying about the stock right now.

Cisco Systems, Inc. (NASDAQ:CSCO)

Cisco facts

Headquarters (founded) San Jose, Calif. (1984)
Market Cap $111.5 billion
Industry Communications equipment
Trailing-12-Month Revenue $46.7 billion
Management Chairman/CEO John ChambersPresident/COO Gary Moore
Return on Equity (average, past 3 years) 16.4%
Cash/Debt $45.0 billion / $16.3 billion
Dividend Yield
Competitors Alcatel-Lucent SA (NYSE:ALU)Hewlett-Packard Company (NYSE:HPQ)

Juniper Networks, Inc. (NYSE:JNPR)

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 95% of the 11,020 members who have rated Cisco believe the stock will outperform the S&P 500 going forward.

Earlier this week, one of those Fools, EVplusEV, tapped the stock as a particularly solid bargain opportunity:

[Cisco] is cheap at 9x forward estimates vs. its five-year average of nearly 13x. Very strong balance sheet. The company has been cutting costs for years and finally seems poised for growth. Attractive dividend and even appears on the [Magic Formula] screen.

Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.

The article Why Cisco Is Poised to Outperform originally appeared on Fool.com.

Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool recommends Cisco Systems.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!